Sandostatin Injection, Solution
Product Images NDC 0078-0182

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sandostatin (NDC 0078-0182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sandostatin 01

Sandostatin 01
This is a description of Sandostatin®, which is an injectable medicine containing octreotide acetate. It comes in ampules of 50 micrograms per milliliter and is used for subcutaneous or intravenous administration under prescription. This description also includes some illegible text.*
FDA Label Image

Octreotide Acetate Amino Acid Sequence (Sandostatin 02)

Octreotide Acetate Amino Acid Sequence (Sandostatin 02)
The text appears to be a molecular formula. Specifically, it is the formula for a peptide molecule made up of the amino acid sequence: H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol. It also includes a side chain notation (*CH;COOH) that may indicate a modification or functionalization of the peptide molecule.*
FDA Label Image

Principal Display Panelpackage Label – 50 Mcg/mlrx Only Ndc 0078 0180 01sandostatin Injection Octreotide Acetate50 Mcg/ml (0.05 mg/ml) (Sandostatin 03)

Principal Display Panelpackage Label – 50 Mcg/mlrx Only		Ndc 0078 0180 01sandostatin Injection Octreotide Acetate50 Mcg/ml (0.05 mg/ml) (Sandostatin 03)
Not available. The text contains non-English characters and random symbols that cannot be used to generate a useful description.*
FDA Label Image

Principal Display Panelpackage Label – 100 Mcg/mlrx Only Ndc 0078 0181 01sandostatin Injectionoctreotide Acetate100 Mcg/ml (0.1 mg/ml) (Sandostatin 04)

Principal Display Panelpackage Label – 100 Mcg/mlrx Only		Ndc 0078 0181 01sandostatin Injectionoctreotide Acetate100 Mcg/ml (0.1 mg/ml) (Sandostatin 04)
This is a description of medication called Sandostatin. It is available in an injection form in a 100 mcg/mL concentration. The medication is used for either subcutaneous or intravenous use. Dosage and administration details are mentioned in the package insert. It is manufactured by Novartis.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.